The HSP co-inducer BGP-15 can prevent the metabolic side effects of the atypical antipsychotics

Weight gain and dysfunction of glucose and lipid metabolism are well-known side effects of atypical antipsychotic drugs (AAPD). Here, we address the question whether a heat-shock protein (HSP) co-inducer, insulin sensitizer drug candidate, BGP-15, can prevent AAPD-induced glucose, lipid, and weight...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Literáti-Nagy, Zsuzsanna, Tory, Kálmán, Literáti-Nagy, Botond, Kolonics, Attila, Török, Zsolt, Gombos, Imre, Balogh, Gábor, Vígh, László, Horváth, Ibolya, Mandl, József, Sümegi, Balázs, Hooper, Philip L.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Springer Netherlands 2012
Konular:
Short Communication
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3368033/
https://ncbi.nlm.nih.gov/pubmed/22322357
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12192-012-0327-5
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller